These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21641061)

  • 41. Usefulness of C-Reactive Protein as a Predictor of Contrast-Induced Nephropathy After Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction and Presentation of a New Risk Score (Athens CIN Score).
    Lazaros G; Zografos T; Oikonomou E; Siasos G; Georgiopoulos G; Vavuranakis M; Antonopoulos A; Kalogeras K; Tsalamandris S; Tousoulis D
    Am J Cardiol; 2016 Nov; 118(9):1329-1333. PubMed ID: 27745963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.
    Barbieri L; Verdoia M; Suryapranata H; De Luca G;
    Int J Cardiol; 2019 Jan; 275():48-52. PubMed ID: 30274753
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of central pulse pressure with contrast-induced nephropathy and clinical outcomes in patients undergoing coronary intervention.
    Huang SS; Huang PH; Leu HB; Wu TC; Lin SJ; Chen JW
    J Hypertens; 2013 Nov; 31(11):2187-94. PubMed ID: 23868087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of Transient or Persistent Contrast-induced Nephropathy on Long-term Mortality After Elective Percutaneous Coronary Intervention.
    Abe M; Morimoto T; Nakagawa Y; Furukawa Y; Ono K; Kato T; Kadota K; Ando K; Ishii M; Masunaga N; Akao M; Kimura T
    Am J Cardiol; 2017 Dec; 120(12):2146-2153. PubMed ID: 29106836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A simple preprocedural score for risk of contrast-induced acute kidney injury after percutaneous coronary intervention.
    Chen YL; Fu NK; Xu J; Yang SC; Li S; Liu YY; Cong HL
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):E8-16. PubMed ID: 23907993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of Serum Osmolarity With Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction.
    Yildiz I; Yildiz PO; Rencuzogullari I; Karabag Y; Cagdas M; Burak C; Gurevin MS
    Angiology; 2019 Aug; 70(7):627-632. PubMed ID: 30712366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of 17 Contrast-Induced Acute Kidney Injury Risk Prediction Models.
    Serif L; Chalikias G; Didagelos M; Stakos D; Kikas P; Thomaidis A; Lantzouraki A; Ziakas A; Tziakas D
    Cardiorenal Med; 2020; 10(3):162-174. PubMed ID: 32289786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.
    Jain T; Shah S; Shah J; Jacobsen G; Khandelwal A
    Crit Pathw Cardiol; 2018 Mar; 17(1):25-31. PubMed ID: 29432373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of metabolic syndrome on development of contrast-induced nephropathy after elective percutaneous coronary intervention among nondiabetic patients.
    Ozcan OU; Adanir Er H; Gulec S; Ustun EE; Gerede DM; Goksuluk H; Tulunay Kaya C; Erol C
    Clin Cardiol; 2015 Mar; 38(3):150-6. PubMed ID: 25800136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.
    Liu Y; Tan N; Zhou YL; Chen YY; Chen JY; Chen J; Luo JF
    J Nephrol; 2012; 25(3):332-40. PubMed ID: 21928234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention.
    Barbieri L; Verdoia M; Marino P; Suryapranata H; De Luca G;
    Eur J Prev Cardiol; 2016 Jun; 23(9):931-7. PubMed ID: 26525064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictive value of preprocedural albuminuria for contrast-induced nephropathy non-recovery in patients undergoing percutaneous coronary intervention.
    Chen H; You Z; Zhang S; He C; He H; Luo M; Lin X; Zhang L; Lin K; Guo Y
    Int Urol Nephrol; 2021 Dec; 53(12):2603-2610. PubMed ID: 33675474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rotational atherectomy-based percutaneous coronary intervention and the risk of contrast-induced nephropathy.
    Demir OM; Poletti E; Lombardo F; Laricchia A; Beneduce A; Maccagni D; Cappelletti A; Colombo A; Bellini B; Ancona MB; Carlino M; Chieffo A; Montorfano M; Azzalini L
    Minerva Cardioangiol; 2020 Apr; 68(2):137-145. PubMed ID: 32100984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarction.
    Lucreziotti S; Centola M; Salerno-Uriarte D; Ponticelli G; Battezzati PM; Castini D; Sponzilli C; Lombardi F
    Int J Cardiol; 2014 Jun; 174(1):37-42. PubMed ID: 24698233
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.
    Chanin JM; Yang DC; Haider MA; Swaminathan RV; Kim LK; Charitakis K; Tanoue M; Minutello RM; Gade CL; Singh HS; Bergman G; Wong SC; Feldman DN
    J Invasive Cardiol; 2015 Nov; 27(11):490-6. PubMed ID: 25999136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The predictive value of hemoglobin to creatinine ratio for contrast-induced nephropathy in percutaneous coronary interventions.
    Çamci S; Kinik M; Ari S; Ari H; Melek M; Bozat T
    Clin Chem Lab Med; 2022 Aug; 60(9):1455-1462. PubMed ID: 35727209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of minimum contrast media volumes during elective percutaneous coronary intervention for prevention of contrast-induced nephropathy in patients with stable coronary artery disease.
    Ebisawa S; Kurita T; Tanaka N; Nasu K; Kimura M; Ito T; Kinoshita Y; Tsuchikane E; Terashima M; Suzuki T
    Cardiovasc Interv Ther; 2016 Jan; 31(1):13-20. PubMed ID: 26001976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does N-terminal pro-brain natriuretic peptide add prognostic value to the Mehran risk score for contrast-induced nephropathy and long-term outcomes after primary percutaneous coronary intervention?
    Liu YH; Jiang L; Chen JY; Tan N; Liu Y; He PC
    Int Urol Nephrol; 2016 Oct; 48(10):1675-82. PubMed ID: 27473154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.
    Barbieri L; Verdoia M; Schaffer A; Cassetti E; Marino P; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):181-6. PubMed ID: 25315668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.
    Fan Y; Wei Q; Cai J; Shi Y; Zhang Y; Yao L; Wang X; Lin S; Li Y; Lv J; Zhou B; Du R
    Heart Vessels; 2016 Nov; 31(11):1776-1782. PubMed ID: 26874946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.